Two Sigma Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$112M Buy
343,305
+145,890
+74% +$47.6M 0.2% 127
2025
Q1
$53.3M Buy
197,415
+90,298
+84% +$24.4M 0.11% 210
2024
Q4
$25.2M Buy
107,117
+87,969
+459% +$20.7M 0.06% 389
2024
Q3
$5.27M Sell
19,148
-83,770
-81% -$23M 0.01% 1015
2024
Q2
$25M Buy
102,918
+406
+0.4% +$98.7K 0.06% 365
2024
Q1
$15.3M Buy
+102,512
New +$15.3M 0.04% 488
2023
Q4
Sell
-3,300
Closed -$584K 3035
2023
Q3
$584K Sell
3,300
-221,369
-99% -$39.2M ﹤0.01% 2143
2023
Q2
$42.7M Buy
224,669
+57,323
+34% +$10.9M 0.11% 230
2023
Q1
$33.5M Sell
167,346
-15,361
-8% -$3.08M 0.1% 241
2022
Q4
$43.4M Sell
182,707
-34,005
-16% -$8.08M 0.14% 171
2022
Q3
$43.4M Buy
+216,712
New +$43.4M 0.15% 171
2022
Q2
Sell
-73,949
Closed -$12.1M 2403
2022
Q1
$12.1M Buy
+73,949
New +$12.1M 0.04% 534
2021
Q2
Sell
-36,619
Closed -$5.17M 2386
2021
Q1
$5.17M Buy
+36,619
New +$5.17M 0.01% 815
2018
Q4
Sell
-20,675
Closed -$1.81M 2061
2018
Q3
$1.81M Sell
20,675
-102,708
-83% -$8.99M ﹤0.01% 1138
2018
Q2
$12.2M Sell
123,383
-132,993
-52% -$13.1M 0.04% 476
2018
Q1
$30.5M Sell
256,376
-46,000
-15% -$5.48M 0.1% 241
2017
Q4
$38.4M Buy
302,376
+158,502
+110% +$20.1M 0.13% 206
2017
Q3
$16.9M Buy
143,874
+141,127
+5,137% +$16.6M 0.06% 337
2017
Q2
$219K Buy
+2,747
New +$219K ﹤0.01% 1858
2017
Q1
Hold
0
2094
2016
Q4
Hold
0
2114
2016
Q3
Hold
0
2004
2016
Q2
Sell
-84,077
Closed -$5.28M 1989
2016
Q1
$5.28M Buy
+84,077
New +$5.28M 0.03% 604
2015
Q3
Sell
-18,630
Closed -$2.23M 1629
2015
Q2
$2.23M Buy
+18,630
New +$2.23M 0.01% 1012
2013
Q3
Sell
-16,190
Closed -$502K 1814
2013
Q2
$502K Buy
+16,190
New +$502K ﹤0.01% 1406